EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis

Jiaxuan Peng, Liujie Chen, Haoyang Hu, Fei Yang iD

Journal of Pain Research · 2026-10 · Volume 19 · 1-8

DOI: 10.2147/jpr.s645854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pain Research, 2026-10. Verfasst von Jiaxuan Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Migraine is a significant public health issue and a leading cause of disability globally. This study quantified the health and productivity burden of migraine among women aged 20-64 years in Western Europe from 2023 to 2029.

Methods

We used a Bayesian productivity-adjusted life-year framework with archived Bayesian age-period-cohort projections. Data were derived from Global Burden of Disease Study 2023 estimates. The analysis included disability-adjusted life years (DALYs), estimated productivity-adjusted life years (PALYs) lost, and productivity-related monetary valuation in 2021 constant international dollars (Int$), discounted to 2023.

Results

From 2023 to 2029, the age-specific inputs summed to 10.867 million DALYs and 1.082 million estimated PALYs lost. The cumulative monetary valuation was Int$69.85 billion, and sensitivity estimates ranged from Int$66.07 billion to Int$76.32 billion. In a separate female age-standardized comparison, Belgium had the highest available 2023 country estimate at 1443.61 DALYs per 100,000 women.

Conclusion

Migraine represents a substantial health and productivity burden among working-age women in Western Europe. The monetary estimate depends on the archived coefficients and valuation inputs and should not be interpreted as observed GDP loss or treatment-attributable savings.

Schlagwörter

Stichwörter der Autor:innen

Western Europedisability-adjusted life yearsglobal burden of disease study 2023migraineproductivity-adjusted life yearsworking-age women

Autor:innen und Institutionen

  • Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
  • Medical School of Chinese PLA, Beijing, 100853, People's Republic of China.
  • International Headache Centre, Chinese PLA General Hospital, Beijing, People's Republic of China.

ORCID-Profile: Fei Yang

Zitieren

APA

Peng, J., Chen, L., Hu, H., & Yang, F. (2026). Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis. Journal of Pain Research, Volume 19, 1-8. https://doi.org/10.2147/jpr.s645854

Vancouver

Peng J, Chen L, Hu H, Yang F. Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis. Journal of Pain Research. 2026;Volume 19:1-8. doi:10.2147/jpr.s645854

BibTeX
@article{Peng2026,
  author = {Peng, Jiaxuan and Chen, Liujie and Hu, Haoyang and Yang, Fei},
  title = {Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--8},
  doi = {10.2147/jpr.s645854}
}
Kostenlos starten →